Chemotherapy is an important treatment for many types of cancer, but it can come with difficult side effects. One of the most common problems patients report is a change in their thinking ability.
This can include trouble focusing, forgetfulness, and difficulty handling more than one task at a time. Many people describe it as a feeling of mental fog.
This condition, often called cancer-related cognitive impairment, affects a large number of patients. Research shows that up to 80 percent of people receiving chemotherapy experience these symptoms. While they are usually not severe, they can still affect quality of life and daily functioning.
Scientists believe that inflammation may play a key role in these cognitive changes. Cancer and its treatments can trigger inflammatory responses in the body, which may also affect the brain. Because of this, researchers are exploring ways to reduce inflammation as a way to protect cognitive function.
A study published in the journal Cancer tested whether exercise and a common anti-inflammatory drug, ibuprofen, could help. The study was led by Michelle C. Janelsins and her team at the University of Rochester.
The researchers designed a clinical trial involving 86 patients who were undergoing chemotherapy and experiencing cognitive problems. The participants were divided into four groups. One group did both exercise and took ibuprofen. Another group exercised but took a placebo. A third group took only ibuprofen, and the final group took only a placebo.
The exercise program used in the study was called EXCAP. It included walking and light strength exercises that could be done at home. The program was designed to be easy to follow and suitable for people undergoing cancer treatment. The study lasted for six weeks.
The results showed that exercise had a strong positive effect. Patients who followed the exercise program had better attention compared to those who did not. This suggests that regular movement, even at a moderate level, can support brain function during treatment.
The ibuprofen-only group also showed some improvement, but the results were mixed. While there were gains in certain areas, the improvements were not as consistent as those seen with exercise. In one test of short-term memory, the ibuprofen group actually showed less improvement than those who did not take the drug.
Another important finding was that people around the patients noticed changes. Friends and family reported fewer signs of cognitive problems in those who exercised. This shows that the benefits were meaningful in real-world situations, not just in laboratory tests.
Despite these encouraging results, the study has limitations. The number of participants was relatively small, and the duration was short. It is not yet clear how long the benefits last or what the best level of exercise might be. More research is needed to answer these questions.
The study also highlights that not all treatments work in the same way. Exercise appears to have broader and more reliable benefits, while ibuprofen may help in some areas but not others. This suggests that different approaches may need to be combined carefully.
In summary, the findings suggest that exercise may be a simple and effective way to reduce cognitive problems during chemotherapy. Ibuprofen may also have some benefits, but its effects are less certain. Patients should always consult their doctor before trying new treatments, especially when medications are involved.
From a research perspective, this study is an important early step. It provides useful evidence but does not yet offer final answers. Larger and longer trials will be needed to confirm these results and guide future treatment strategies.
If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.
For more health information, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.
Source: University of Rochester.
